Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!

Trump Preparing Executive Order On Drug Prices; Spec Pharma Stocks Slide To One Month Lows

Courtesy of ZeroHedge. View original post here.

Specialty pharma stocks are dropping – again - on news that the Trump administration is preparing an executive order – again - targeting lower U.S. drug costs. Bloomberg reports that the order addressing the sensitive campaign issue could come within weeks and has been largely left out of Republican legislative efforts in Congress, until now.

As a result of the report, the Bloomberg Specialty-Generic Pharma index has dropped as much as 1.24%, its lowest in a month, with the drop led by the usual suspects: VRX -3%, MYL -2.7%, ENDP – 2.7%, MNK -1.2%.

Some more details from Bloomberg, which writes that top health and budget officials in the administration will meet Friday to discuss the issues, according to the people, who asked not to be identified because the session is private. Trump sought recommendations from the nation’s health agencies on reducing medication costs, Health and Human Services SecretaryTom Price told senators last week.

One policy being discussed for inclusion in the order is expressing support forvalue-based agreements, a drug industry-backed proposal in which pharmaceutical companies and health insurers develop arrangements to pay for products depending on how well they work, one of the people said. Price, Centers for Medicare and Medicaid Services Administrator Seema Verma, Food and Drug Administration Commissioner Scott Gottlieb and Treasury Secretary Steve Mnuchin are expected to attend the meeting Friday, which is being led by Office of Management and Budget Director Mick Mulvaney, according to the people.

The recommendations from the officials may be used to craft a first executive order on drug prices that could come out soon, according to the people, followed by a second, more extensive order later. While executive orders can’t change laws, Trump could use the efforts to direct agencies to explore regulatory changes and set direction.

The development is hardly new, with Trump having threatened on several occasions to force drugmakers to bid for government business as a way to reduce prices. He’s also talked about letting consumers import drugs from other countries with lower prices. Neither of those policies, which would likely require a change in law to be implemented in a meaningful way, are in drafts of the orders.


Do you know someone who would benefit from this information? We can send your friend a strictly confidential, one-time email telling them about this information. Your privacy and your friend's privacy is your business... no spam! Click here and tell a friend!





You must be logged in to make a comment.
You can sign up for a membership or get a FREE Daily News membership or log in

Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!